Loading…
Clinical Diagnosis of Hypertrophic Cardiomyopathy Over Time in the United States (A Population-Based Claims Analysis)
Hypertrophic cardiomyopathy (HC) is a common genetic heart disease. However, the number of gene mutation carriers who develop HC and manifest clinical symptoms is not well established. Our objective was to estimate annual prevalence and incidence rates of clinically diagnosed HC in the United States...
Saved in:
| Published in: | The American journal of cardiology 2021-11, Vol.159, p.107-112 |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c417t-591c95adee5c7d2891a76646f70e389a10c1a690032c1f07a5593d15b23e9d993 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c417t-591c95adee5c7d2891a76646f70e389a10c1a690032c1f07a5593d15b23e9d993 |
| container_end_page | 112 |
| container_issue | |
| container_start_page | 107 |
| container_title | The American journal of cardiology |
| container_volume | 159 |
| creator | Butzner, Michael Maron, Martin Sarocco, Phil Rowin, Ethan Teng, Chia-Chen Tan, Hiangkiat Stanek, Eric Robertson, Laura |
| description | Hypertrophic cardiomyopathy (HC) is a common genetic heart disease. However, the number of gene mutation carriers who develop HC and manifest clinical symptoms is not well established. Our objective was to estimate annual prevalence and incidence rates of clinically diagnosed HC in the United States. Data from the HealthCore Integrated Research Database (HIRD) were interrogated for years 2013–2019 to identify patients with ≥1 claim of HC International Classification of Diseases, Clinical Modification Ninth and Tenth Revision diagnosis codes. In 2013, among 16,243,109 patients, 8,526 were identified with HC, yielding an estimated prevalence of clinically diagnosed HC of 0.052% (0.035% for obstructive [oHC], 0.017% for nonobstructive [nHC]). This prevalence yielded an estimated 164,403 patients with clinical diagnosis of HC. For the same year, the incidence of new HC diagnoses was 0.030% (0.020% for oHC, 0.010% for nHC). Over the following 6 years, prevalence and incidence of HC increased by 0.005%/year (p |
| doi_str_mv | 10.1016/j.amjcard.2021.08.024 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2571916910</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914921007839</els_id><sourcerecordid>2581758967</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-591c95adee5c7d2891a76646f70e389a10c1a690032c1f07a5593d15b23e9d993</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhiMEUpfCT6hkiUs5JHiSdRyf0BJailSpSLRna3AmrKMkDrZTKf8er7YnLpxGo3nmnY83y66AF8Ch_jQUOA0GfVeUvISCNwUv96-yHTRS5aCgep3tOOdlrmCvLrK3IQwpBRD1Llvb0c7W4Mi-Wvw9u2ADcz272xby0bvlaA1rk7R10-YWjMeNPTyTZ492ImZnFo_EnmYbqWM_I0YK7PrAfrhlHTFaN-dfMKRSO6KdAjvMOG5pwsd32Zsex0DvX-Jl9nR789je5fcP3763h_vc7EHGXCgwSmBHJIzsykYByrre173kVDUKgRvAWnFelQZ6LlEIVXUgfpUVqU6p6jK7Pusu3v1ZKUQ92WBoHHEmtwZdCpn-UyvgCf3wDzq41aeFT1QDUjSqlokSZ8p4F4KnXi_eTug3DVyfzNCDfjFDn8zQvNHJjNT3-dxH6dpnS14HY2k21FlPJurO2f8o_AWDtpSE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2581758967</pqid></control><display><type>article</type><title>Clinical Diagnosis of Hypertrophic Cardiomyopathy Over Time in the United States (A Population-Based Claims Analysis)</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Butzner, Michael ; Maron, Martin ; Sarocco, Phil ; Rowin, Ethan ; Teng, Chia-Chen ; Tan, Hiangkiat ; Stanek, Eric ; Robertson, Laura</creator><creatorcontrib>Butzner, Michael ; Maron, Martin ; Sarocco, Phil ; Rowin, Ethan ; Teng, Chia-Chen ; Tan, Hiangkiat ; Stanek, Eric ; Robertson, Laura</creatorcontrib><description>Hypertrophic cardiomyopathy (HC) is a common genetic heart disease. However, the number of gene mutation carriers who develop HC and manifest clinical symptoms is not well established. Our objective was to estimate annual prevalence and incidence rates of clinically diagnosed HC in the United States. Data from the HealthCore Integrated Research Database (HIRD) were interrogated for years 2013–2019 to identify patients with ≥1 claim of HC International Classification of Diseases, Clinical Modification Ninth and Tenth Revision diagnosis codes. In 2013, among 16,243,109 patients, 8,526 were identified with HC, yielding an estimated prevalence of clinically diagnosed HC of 0.052% (0.035% for obstructive [oHC], 0.017% for nonobstructive [nHC]). This prevalence yielded an estimated 164,403 patients with clinical diagnosis of HC. For the same year, the incidence of new HC diagnoses was 0.030% (0.020% for oHC, 0.010% for nHC). Over the following 6 years, prevalence and incidence of HC increased by 0.005%/year (p <0.01) and 0.001%/year (p <0.01), respectively, with an estimated 262,591 patients with a clinical diagnosis of HC in 2019. Over this period, incidence of nHC increased (0.012% vs 0.026%, p <0.01), whereas incidence of oHC decreased (0.020% versus 0.015%, p <0.01). In conclusion, over 6 years, the number of patients with clinically diagnosed HC in the United States increased 1.5-fold to ∼262,591, primarily because of a rise in nHC diagnoses. These prevalence data support further investigation to better understand factors accounting for increasing clinical recognition of HC.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2021.08.024</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Calendars ; Cardiology ; Cardiomyopathy ; Cardiovascular diseases ; Codes ; Coronary artery disease ; Diagnosis ; Diagnostic tests ; Disease ; Enrollments ; Health insurance ; Heart diseases ; Insurance claims ; Magnetic resonance imaging ; Medical diagnosis ; Medicare ; Mutation ; Patients ; Pharmacy ; Point mutation ; Population ; Signs and symptoms</subject><ispartof>The American journal of cardiology, 2021-11, Vol.159, p.107-112</ispartof><rights>2021 The Authors</rights><rights>2021. The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-591c95adee5c7d2891a76646f70e389a10c1a690032c1f07a5593d15b23e9d993</citedby><cites>FETCH-LOGICAL-c417t-591c95adee5c7d2891a76646f70e389a10c1a690032c1f07a5593d15b23e9d993</cites><orcidid>0000-0002-6015-7910</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Butzner, Michael</creatorcontrib><creatorcontrib>Maron, Martin</creatorcontrib><creatorcontrib>Sarocco, Phil</creatorcontrib><creatorcontrib>Rowin, Ethan</creatorcontrib><creatorcontrib>Teng, Chia-Chen</creatorcontrib><creatorcontrib>Tan, Hiangkiat</creatorcontrib><creatorcontrib>Stanek, Eric</creatorcontrib><creatorcontrib>Robertson, Laura</creatorcontrib><title>Clinical Diagnosis of Hypertrophic Cardiomyopathy Over Time in the United States (A Population-Based Claims Analysis)</title><title>The American journal of cardiology</title><description>Hypertrophic cardiomyopathy (HC) is a common genetic heart disease. However, the number of gene mutation carriers who develop HC and manifest clinical symptoms is not well established. Our objective was to estimate annual prevalence and incidence rates of clinically diagnosed HC in the United States. Data from the HealthCore Integrated Research Database (HIRD) were interrogated for years 2013–2019 to identify patients with ≥1 claim of HC International Classification of Diseases, Clinical Modification Ninth and Tenth Revision diagnosis codes. In 2013, among 16,243,109 patients, 8,526 were identified with HC, yielding an estimated prevalence of clinically diagnosed HC of 0.052% (0.035% for obstructive [oHC], 0.017% for nonobstructive [nHC]). This prevalence yielded an estimated 164,403 patients with clinical diagnosis of HC. For the same year, the incidence of new HC diagnoses was 0.030% (0.020% for oHC, 0.010% for nHC). Over the following 6 years, prevalence and incidence of HC increased by 0.005%/year (p <0.01) and 0.001%/year (p <0.01), respectively, with an estimated 262,591 patients with a clinical diagnosis of HC in 2019. Over this period, incidence of nHC increased (0.012% vs 0.026%, p <0.01), whereas incidence of oHC decreased (0.020% versus 0.015%, p <0.01). In conclusion, over 6 years, the number of patients with clinically diagnosed HC in the United States increased 1.5-fold to ∼262,591, primarily because of a rise in nHC diagnoses. These prevalence data support further investigation to better understand factors accounting for increasing clinical recognition of HC.</description><subject>Calendars</subject><subject>Cardiology</subject><subject>Cardiomyopathy</subject><subject>Cardiovascular diseases</subject><subject>Codes</subject><subject>Coronary artery disease</subject><subject>Diagnosis</subject><subject>Diagnostic tests</subject><subject>Disease</subject><subject>Enrollments</subject><subject>Health insurance</subject><subject>Heart diseases</subject><subject>Insurance claims</subject><subject>Magnetic resonance imaging</subject><subject>Medical diagnosis</subject><subject>Medicare</subject><subject>Mutation</subject><subject>Patients</subject><subject>Pharmacy</subject><subject>Point mutation</subject><subject>Population</subject><subject>Signs and symptoms</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNqFkU1v1DAQhiMEUpfCT6hkiUs5JHiSdRyf0BJailSpSLRna3AmrKMkDrZTKf8er7YnLpxGo3nmnY83y66AF8Ch_jQUOA0GfVeUvISCNwUv96-yHTRS5aCgep3tOOdlrmCvLrK3IQwpBRD1Llvb0c7W4Mi-Wvw9u2ADcz272xby0bvlaA1rk7R10-YWjMeNPTyTZ492ImZnFo_EnmYbqWM_I0YK7PrAfrhlHTFaN-dfMKRSO6KdAjvMOG5pwsd32Zsex0DvX-Jl9nR789je5fcP3763h_vc7EHGXCgwSmBHJIzsykYByrre173kVDUKgRvAWnFelQZ6LlEIVXUgfpUVqU6p6jK7Pusu3v1ZKUQ92WBoHHEmtwZdCpn-UyvgCf3wDzq41aeFT1QDUjSqlokSZ8p4F4KnXi_eTug3DVyfzNCDfjFDn8zQvNHJjNT3-dxH6dpnS14HY2k21FlPJurO2f8o_AWDtpSE</recordid><startdate>20211115</startdate><enddate>20211115</enddate><creator>Butzner, Michael</creator><creator>Maron, Martin</creator><creator>Sarocco, Phil</creator><creator>Rowin, Ethan</creator><creator>Teng, Chia-Chen</creator><creator>Tan, Hiangkiat</creator><creator>Stanek, Eric</creator><creator>Robertson, Laura</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6015-7910</orcidid></search><sort><creationdate>20211115</creationdate><title>Clinical Diagnosis of Hypertrophic Cardiomyopathy Over Time in the United States (A Population-Based Claims Analysis)</title><author>Butzner, Michael ; Maron, Martin ; Sarocco, Phil ; Rowin, Ethan ; Teng, Chia-Chen ; Tan, Hiangkiat ; Stanek, Eric ; Robertson, Laura</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-591c95adee5c7d2891a76646f70e389a10c1a690032c1f07a5593d15b23e9d993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Calendars</topic><topic>Cardiology</topic><topic>Cardiomyopathy</topic><topic>Cardiovascular diseases</topic><topic>Codes</topic><topic>Coronary artery disease</topic><topic>Diagnosis</topic><topic>Diagnostic tests</topic><topic>Disease</topic><topic>Enrollments</topic><topic>Health insurance</topic><topic>Heart diseases</topic><topic>Insurance claims</topic><topic>Magnetic resonance imaging</topic><topic>Medical diagnosis</topic><topic>Medicare</topic><topic>Mutation</topic><topic>Patients</topic><topic>Pharmacy</topic><topic>Point mutation</topic><topic>Population</topic><topic>Signs and symptoms</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Butzner, Michael</creatorcontrib><creatorcontrib>Maron, Martin</creatorcontrib><creatorcontrib>Sarocco, Phil</creatorcontrib><creatorcontrib>Rowin, Ethan</creatorcontrib><creatorcontrib>Teng, Chia-Chen</creatorcontrib><creatorcontrib>Tan, Hiangkiat</creatorcontrib><creatorcontrib>Stanek, Eric</creatorcontrib><creatorcontrib>Robertson, Laura</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest research library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Butzner, Michael</au><au>Maron, Martin</au><au>Sarocco, Phil</au><au>Rowin, Ethan</au><au>Teng, Chia-Chen</au><au>Tan, Hiangkiat</au><au>Stanek, Eric</au><au>Robertson, Laura</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical Diagnosis of Hypertrophic Cardiomyopathy Over Time in the United States (A Population-Based Claims Analysis)</atitle><jtitle>The American journal of cardiology</jtitle><date>2021-11-15</date><risdate>2021</risdate><volume>159</volume><spage>107</spage><epage>112</epage><pages>107-112</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><abstract>Hypertrophic cardiomyopathy (HC) is a common genetic heart disease. However, the number of gene mutation carriers who develop HC and manifest clinical symptoms is not well established. Our objective was to estimate annual prevalence and incidence rates of clinically diagnosed HC in the United States. Data from the HealthCore Integrated Research Database (HIRD) were interrogated for years 2013–2019 to identify patients with ≥1 claim of HC International Classification of Diseases, Clinical Modification Ninth and Tenth Revision diagnosis codes. In 2013, among 16,243,109 patients, 8,526 were identified with HC, yielding an estimated prevalence of clinically diagnosed HC of 0.052% (0.035% for obstructive [oHC], 0.017% for nonobstructive [nHC]). This prevalence yielded an estimated 164,403 patients with clinical diagnosis of HC. For the same year, the incidence of new HC diagnoses was 0.030% (0.020% for oHC, 0.010% for nHC). Over the following 6 years, prevalence and incidence of HC increased by 0.005%/year (p <0.01) and 0.001%/year (p <0.01), respectively, with an estimated 262,591 patients with a clinical diagnosis of HC in 2019. Over this period, incidence of nHC increased (0.012% vs 0.026%, p <0.01), whereas incidence of oHC decreased (0.020% versus 0.015%, p <0.01). In conclusion, over 6 years, the number of patients with clinically diagnosed HC in the United States increased 1.5-fold to ∼262,591, primarily because of a rise in nHC diagnoses. These prevalence data support further investigation to better understand factors accounting for increasing clinical recognition of HC.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/j.amjcard.2021.08.024</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-6015-7910</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-9149 |
| ispartof | The American journal of cardiology, 2021-11, Vol.159, p.107-112 |
| issn | 0002-9149 1879-1913 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2571916910 |
| source | ScienceDirect Freedom Collection 2022-2024 |
| subjects | Calendars Cardiology Cardiomyopathy Cardiovascular diseases Codes Coronary artery disease Diagnosis Diagnostic tests Disease Enrollments Health insurance Heart diseases Insurance claims Magnetic resonance imaging Medical diagnosis Medicare Mutation Patients Pharmacy Point mutation Population Signs and symptoms |
| title | Clinical Diagnosis of Hypertrophic Cardiomyopathy Over Time in the United States (A Population-Based Claims Analysis) |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T13%3A27%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20Diagnosis%20of%20Hypertrophic%20Cardiomyopathy%20Over%20Time%20in%20the%20United%20States%20(A%20Population-Based%20Claims%20Analysis)&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Butzner,%20Michael&rft.date=2021-11-15&rft.volume=159&rft.spage=107&rft.epage=112&rft.pages=107-112&rft.issn=0002-9149&rft.eissn=1879-1913&rft_id=info:doi/10.1016/j.amjcard.2021.08.024&rft_dat=%3Cproquest_cross%3E2581758967%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c417t-591c95adee5c7d2891a76646f70e389a10c1a690032c1f07a5593d15b23e9d993%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2581758967&rft_id=info:pmid/&rfr_iscdi=true |